Xiaoling Xu

3.4k total citations · 1 hit paper
77 papers, 2.4k citations indexed

About

Xiaoling Xu is a scholar working on Biomedical Engineering, Molecular Biology and Biomaterials. According to data from OpenAlex, Xiaoling Xu has authored 77 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Biomedical Engineering, 24 papers in Molecular Biology and 19 papers in Biomaterials. Recurrent topics in Xiaoling Xu's work include Nanoplatforms for cancer theranostics (27 papers), Nanoparticle-Based Drug Delivery (17 papers) and RNA Interference and Gene Delivery (5 papers). Xiaoling Xu is often cited by papers focused on Nanoplatforms for cancer theranostics (27 papers), Nanoparticle-Based Drug Delivery (17 papers) and RNA Interference and Gene Delivery (5 papers). Xiaoling Xu collaborates with scholars based in China, Czechia and Japan. Xiaoling Xu's co-authors include Yongzhong Du, Jing Qi, Xiaoying Ying, Gaofeng Shu, Jiansong Ji, Feiyang Jin, Yuchan You, Xu-Qi Kang, Di Liu and Luwen Zhu and has published in prestigious journals such as Advanced Materials, Nature Communications and Nano Letters.

In The Last Decade

Xiaoling Xu

70 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adipose‐Derived Mesenchymal Stem Cell‐Derived Exosomes Biopotentiated Extracellular Matrix Hydrogels Accelerate Diabetic Wound Healing and Skin Regeneration

2023 153 citations Yanling Song, Yuchan You et al. Advanced Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaoling Xu China	29	978	783	609	351	344	77	2.4k
Gaofeng Shu China	29	933 1.0×	775 1.0×	510 0.8×	509 1.5×	265 0.8×	68	2.8k
Xiaojing Zhao China	28	817 0.8×	1.1k 1.5×	548 0.9×	465 1.3×	418 1.2×	115	3.0k
In‐Kyu Park South Korea	26	1.1k 1.2×	834 1.1×	732 1.2×	408 1.2×	249 0.7×	62	2.3k
Qin Wang China	30	1.1k 1.1×	883 1.1×	415 0.7×	454 1.3×	291 0.8×	126	2.9k
Caiwen Ou China	35	489 0.5×	1.3k 1.6×	729 1.2×	225 0.6×	192 0.6×	107	2.9k
Wei Shi China	28	556 0.6×	887 1.1×	529 0.9×	220 0.6×	263 0.8×	136	2.8k
Zhigui Su China	27	858 0.9×	1.0k 1.3×	912 1.5×	269 0.8×	145 0.4×	57	2.4k
Xinru You China	30	859 0.9×	900 1.1×	918 1.5×	314 0.9×	150 0.4×	61	2.4k

Countries citing papers authored by Xiaoling Xu

Since Specialization

Citations

This map shows the geographic impact of Xiaoling Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Xu more than expected).

Fields of papers citing papers by Xiaoling Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoling Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Xu. The network helps show where Xiaoling Xu may publish in the future.

Co-authorship network of co-authors of Xiaoling Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoling Xu. A scholar is included among the top collaborators of Xiaoling Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoling Xu. Xiaoling Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Lu, et al.. (2025). Nanodrug Delivery Systems for Direct Clearance or Neutralization of LPS. International Journal of Nanomedicine. Volume 20. 8653–8673. 1 indexed citations

Li, Lei, Jingbo Zhou, Yuzhong Peng, et al.. (2025). Proteasomes suppress anticancer drug-induced cytotoxicity by inhibiting mitochondrial protein import and promoting ROS-BNIP3-mediated mitophagy. Drug Resistance Updates. 83. 101294–101294.

Li, Zhen, Xiaoliang Qian, Nannan Sun, et al.. (2024). MolProphet: A One-Stop, General Purpose, and AI-Based Platform for the Early Stages of Drug Discovery. Journal of Chemical Information and Modeling. 64(8). 2941–2947. 13 indexed citations

Song, Yue, et al.. (2023). Recent advances of cell membrane-coated nanoparticles for therapy of bacterial infection. Frontiers in Microbiology. 14. 1083007–1083007. 26 indexed citations

Lou, Xue-Fang, Jingyi Lu, Chen Wang, et al.. (2023). Self-oriented ferritin nanocages mitigate iron overload-induced oxidative stress for acute kidney injury. Chemical Engineering Journal. 466. 143227–143227. 14 indexed citations

Hu, Jiahao, Yuchan You, Luwen Zhu, et al.. (2023). Sialic Acid‐Functionalized Pyroptosis Nanotuner for Epigenetic Regulation and Enhanced Cancer Immunotherapy. Small. 20(10). e2306905–e2306905. 12 indexed citations

Liu, Di, Yanling Song, Hui Chen, et al.. (2023). Anti-VEGFR2 F(ab′)2 drug conjugate promotes renal accumulation and glomerular repair in diabetic nephropathy. Nature Communications. 14(1). 8268–8268. 7 indexed citations

Xu, Xiaoling, et al.. (2023). Combining nanotechnology with monoclonal antibody drugs for rheumatoid arthritis treatments. Journal of Nanobiotechnology. 21(1). 105–105. 25 indexed citations

Song, Yanling, Yuchan You, Xinyi Xu, et al.. (2023). Adipose‐Derived Mesenchymal Stem Cell‐Derived Exosomes Biopotentiated Extracellular Matrix Hydrogels Accelerate Diabetic Wound Healing and Skin Regeneration. Advanced Science. 10(30). e2304023–e2304023. 153 indexed citations breakdown →

10.

Xu, Xiaoling, Xi‐Chen Wu, Yuelong Cao, et al.. (2022). Nanodevices for deep cartilage penetration. Acta Biomaterialia. 154. 23–48. 28 indexed citations

11.

Zhang, Nannan, Gaofeng Shu, Enqi Qiao, et al.. (2022). DNA-Functionalized Liposomes In Vivo Fusion for NIR-II/MRI Guided Pretargeted Ferroptosis Therapy of Metastatic Breast Cancer. ACS Applied Materials & Interfaces. 14(18). 20603–20615. 17 indexed citations

12.

Chen, Minjiang, Gaofeng Shu, Xiuling Lv, et al.. (2022). HIF-2α-targeted interventional chemoembolization multifunctional microspheres for effective elimination of hepatocellular carcinoma. Biomaterials. 284. 121512–121512. 45 indexed citations

13.

Chen, Minjiang, Xiaoling Xu, Gaofeng Shu, et al.. (2021). Multifunctional Microspheres Dual-Loaded with Doxorubicin and Sodium Bicarbonate Nanoparticles to Introduce Synergistic Trimodal Interventional Therapy. ACS Applied Bio Materials. 4(4). 3476–3489. 11 indexed citations

14.

Wang, Jun, Jing Qi, Feiyang Jin, et al.. (2021). Spatiotemporally light controlled “drug-free” macromolecules via upconversion-nanoparticle for precise tumor therapy. Nano Today. 42. 101360–101360. 16 indexed citations

15.

Liu, Di, Gaofeng Shu, Feiyang Jin, et al.. (2020). ROS-responsive chitosan-SS31 prodrug for AKI therapy via rapid distribution in the kidney and long-term retention in the renal tubule. Science Advances. 6(41). 161 indexed citations

16.

Shu, Gaofeng, Chenying Lu, Zhixian Wang, et al.. (2020). Fucoidan-based micelles as P-selectin targeted carriers for synergistic treatment of acute kidney injury. Nanomedicine Nanotechnology Biology and Medicine. 32. 102342–102342. 27 indexed citations

17.

Qi, Jing, Xiaoling Xu, Feiyang Jin, et al.. (2020). Cyto-friendly polymerization at cell surfaces modulates cell fate by clustering cell-surface receptors. Chemical Science. 11(16). 4221–4225. 26 indexed citations

18.

Xu, Xiaoling, Xu-Qi Kang, Jing Qi, et al.. (2019). Novel Antibacterial Strategies for Combating Bacterial Multidrug Resistance. Current Pharmaceutical Design. 25(44). 4717–4724. 9 indexed citations

19.

Xu, Xiaoling, Kong-jun Lu, Menglu Zhu, et al.. (2018). Sialic Acid-Functionalized pH-Triggered Micelles for Enhanced Tumor Tissue Accumulation and Active Cellular Internalization of Orthotopic Hepatocarcinoma. ACS Applied Materials & Interfaces. 10(38). 31903–31914. 35 indexed citations

20.

Xu, Xiaoling, Xiaojuan Wang, Xu-Qi Kang, et al.. (2018). Endogenous sialic acid-engineered micelles: a multifunctional platform for on-demand methotrexate delivery and bone repair of rheumatoid arthritis. Nanoscale. 10(6). 2923–2935. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gaofeng Shu Breakdown of academic impact, for papers by Xiaojing Zhao Breakdown of academic impact, for papers by In‐Kyu Park Breakdown of academic impact, for papers by Qin Wang Breakdown of academic impact, for papers by Caiwen Ou Breakdown of academic impact, for papers by Wei Shi Breakdown of academic impact, for papers by Zhigui Su Breakdown of academic impact, for papers by Xinru You